Moderate to Severe Upper Facial Lines
2 drugs in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 1(1)
| Drug | Company |
|---|---|
| IPN10200 | Revance Therapeutics, Inc. (RVNC) |
Phase 4(1)
| Drug | Company |
|---|---|
| Dysport | Revance Therapeutics, Inc. (RVNC) |
Compare drugs
Frequently asked questions
How many drugs are in development for Moderate to Severe Upper Facial Lines?
BioSniper tracks 2 drugs in development for Moderate to Severe Upper Facial Lines across 1 company.
How many clinical trials target Moderate to Severe Upper Facial Lines?
There are 1 clinical trial targeting Moderate to Severe Upper Facial Lines tracked by BioSniper.
Deep-dive into Moderate to Severe Upper Facial Lines
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis